凯瑟琳 · 艾班: 关于仿制药的一剂现实真相

关于仿制药的一剂现实真相

调查记者凯瑟琳·艾班（Katherine Eban）开始着手报道一个看似直接的问题：仿制药是否真正等效于它们的同名品牌药？寻找这个问题的答案激发了长达十年的采访、与知情者的会面、跨越四大洲的实地探访，以及对美国食物及药品管理局（FDA）机密文件的深入调查。在这次令人警醒的演讲中，她带我们进入海外的制药厂，并揭露了许多廉价仿制药背后的欺诈。

Many generic drugs, relied on by 90 percent of patients in the US, are manufactured in overseas plants that routinely cut corners and falsify data. Investigations uncovered widespread fraud, dangerous impurities, and regulatory blind spots, including FDA inspections announced months in advance. Whistleblowers risked their careers to expose these practices, revealing a global system that sometimes puts patient lives in jeopardy for profit. True safety requires rigorous oversight, not trust alone.